Prior Antibodies to Infliximab or Adalimumab Are Related to Immunogenicity to Vedolizumab in Patients With Inflammatory Bowel Disease

Konstantinos Papamichael, Niels Vande Casteele, Bincy P. Abraham, Timothy Ritter, Anjali Jain, Adam S. Cheifetz

Research output: Contribution to journal › Short survey › peer-review

Original language	English (US)
Journal	Clinical Gastroenterology and Hepatology
DOIs	https://doi.org/10.1016/j.cgh.2022.10.037
State	Accepted/In press - 2023

ASJC Scopus subject areas

@article{afd5f1b791d343e1938566f2e1a981ab,

title = "Prior Antibodies to Infliximab or Adalimumab Are Related to Immunogenicity to Vedolizumab in Patients With Inflammatory Bowel Disease",

author = "Konstantinos Papamichael and {Vande Casteele}, Niels and Abraham, {Bincy P.} and Timothy Ritter and Anjali Jain and Cheifetz, {Adam S.}",

year = "2023",

doi = "10.1016/j.cgh.2022.10.037",

language = "English (US)",

journal = "Clinical Gastroenterology and Hepatology",

issn = "1542-3565",

publisher = "W.B. Saunders Ltd",

}

TY - JOUR

T1 - Prior Antibodies to Infliximab or Adalimumab Are Related to Immunogenicity to Vedolizumab in Patients With Inflammatory Bowel Disease

AU - Papamichael, Konstantinos

AU - Vande Casteele, Niels

AU - Abraham, Bincy P.

AU - Ritter, Timothy

AU - Jain, Anjali

AU - Cheifetz, Adam S.

PY - 2023

Y1 - 2023

UR - http://www.scopus.com/inward/record.url?scp=85146060127&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85146060127&partnerID=8YFLogxK

U2 - 10.1016/j.cgh.2022.10.037

DO - 10.1016/j.cgh.2022.10.037

M3 - Short survey

C2 - 36372372

AN - SCOPUS:85146060127

JO - Clinical Gastroenterology and Hepatology

JF - Clinical Gastroenterology and Hepatology

SN - 1542-3565

ER -